An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2016
At a glance
- Drugs Lenvatinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Eisai Inc
- 22 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 May 2008 Results will be presented at the Annual Meeting of the American Society of Clinical Oncology 2008.